ReviewIndian journal of pharmacology2026

Combined use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for cardiovascular protection.

Soumya Shanta Mohanty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.